Alendronate
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Istituto Auxologico Italiano
Overview
Alendronate is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Alendronate clinical trials
Explore related
Medical disclaimer. This page summarizes research about Alendronate for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.